Breaking News

CRISPR Therapeutics posts wider-than-expected Q4 loss of $1.37/share on zero revenue; shares sink 10% as cash burn accelerates.

**Cadre Holdings Reports Q4 2025 Earnings Miss**

Broadwind Energy reports Q4 loss of $0.05 per share on revenue of $37M, up 10% year-over-year, with fiscal 2026 guidance…

Serve Robotics Inc (SERV) posted a Q4 2025 adjusted loss of $0.49 per share, wider than the -$0.44 expected loss…

Acacia Research reports Q4 adjusted EPS of $0.03, up 122.5% year-over-year, with revenue of $50.1M rising 2.6% from the prior…

Acacia Research Corp (ACTG) reported fourth-quarter 2025 financial results. Acacia Research Corp (ACTG) posted Q4 2025 adjusted EPS of $0.03.…

**Minerva Neurosciences Reports Q4 2025 Results**

**Verrica Pharmaceuticals Reports Q4 2025 Results**

BridgeBio posts wider-than-expected Q4 loss of $0.94/share on $154.2M revenue; stock surges 13% despite 50.6% earnings miss.

Rapport Therapeutics Inc (RAPP) posted a Q4 2025 gaap loss of $0.72 per share, wider than the -$0.67 expected loss…